Teva Pharmaceuticals USA
teva.comTotal trials
176
Active
0
Phase 3
9
Total enrollment
15,932
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Healthy161
- Seasonal Allergic Rhinitis3
- Actinic Keratosis2
- Acne Vulgaris2
- Bacterial Vaginosis1
- Evaluation of QTc Interval1
- Osteoporosis, Postmenopausal1
- Dyspareunia1
Frequently asked questions about Teva Pharmaceuticals USA
- How many clinical trials does Teva Pharmaceuticals USA have on ClinicalTrials.gov?
- Teva Pharmaceuticals USA is listed as the lead sponsor on 176 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Teva Pharmaceuticals USA's trials are in Phase 3?
- 9 of Teva Pharmaceuticals USA's trials are in Phase 3.
- What therapeutic areas does Teva Pharmaceuticals USA focus on?
- Teva Pharmaceuticals USA's most-studied conditions on ClinicalTrials.gov are Healthy, Seasonal Allergic Rhinitis, Actinic Keratosis, Acne Vulgaris, Bacterial Vaginosis.